4//SEC Filing
Nash Duane 4
Accession 0001193805-24-000324
CIK 0001280776other
Filed
Mar 5, 7:00 PM ET
Accepted
Mar 6, 9:52 PM ET
Size
25.2 KB
Accession
0001193805-24-000324
Insider Transaction Report
Form 4
IMMUNIC, INC.IMUX
Nash Duane
See Remarks
Transactions
- Disposition to Issuer
Stock Option
2024-03-04−120,000→ 0 totalExercise: $17.00Exp: 2030-10-22→ Common Stock (120,000 underlying) - Disposition to Issuer
Stock Option
2024-03-04−90,000→ 0 totalExercise: $15.44Exp: 2031-04-15→ Common Stock (90,000 underlying) - Disposition to Issuer
Stock Option
2024-03-04−75,000→ 0 totalExercise: $10.88Exp: 2032-03-10→ Common Stock (75,000 underlying) - Award
Stock Option
2024-03-04+379,959→ 379,959 totalExercise: $1.72→ Common Stock (379,959 underlying) - Disposition to Issuer
Stock Option
2024-03-04−19,973→ 0 totalExercise: $13.63Exp: 2029-07-22→ Common Stock (19,973 underlying) - Disposition to Issuer
Stock Option
2024-03-04−30,000→ 0 totalExercise: $12.30Exp: 2030-07-02→ Common Stock (30,000 underlying) - Disposition to Issuer
Stock Option
2024-03-04−10,000→ 0 totalExercise: $3.40Exp: 2032-06-15→ Common Stock (10,000 underlying) - Disposition to Issuer
Stock Option
2024-03-04−9,986→ 0 totalExercise: $13.63Exp: 2029-07-22→ Common Stock (9,986 underlying) - Disposition to Issuer
Stock Option
2024-03-04−15,000→ 0 totalExercise: $12.30Exp: 2030-07-02→ Common Stock (15,000 underlying) - Disposition to Issuer
Stock Option
2024-03-04−10,000→ 0 totalExercise: $14.77Exp: 2031-06-10→ Common Stock (10,000 underlying)
Footnotes (1)
- [F1]On March 4, 2024, the stockholders of Immunic, Inc. approved a proposal to reduce the exercise price of all employee stock options having an exercise price above $3.00 per share (the "Eligible Options") to the greater of $1.72 and 110% of the closing price on a future repricing date to be set by the Board of Directors. The Board of Directors then determined that the exercise price of all Eligible Options will be repriced to $1.72 per share, which is greater than 110% of the closing price of the Common Stock on March 4, 2024, the repricing date set by the Board of Directors. Accordingly, this Form 4 reflects the cancellation of each Eligible Option and the reissuance of all Eligible Options at an exercise price of $1.72 per share. Following the repricing, each Eligible Option retains its respective original vesting schedule and expiration date.
Documents
Issuer
IMMUNIC, INC.
CIK 0001280776
Entity typeother
Related Parties
1- filerCIK 0001591098
Filing Metadata
- Form type
- 4
- Filed
- Mar 5, 7:00 PM ET
- Accepted
- Mar 6, 9:52 PM ET
- Size
- 25.2 KB